跳至主要内容
临床试验/EUCTR2020-000934-16-NL
EUCTR2020-000934-16-NL进行中(未招募)1 期

Reconsolidation: a new intervention towards combat-related PTSD. - #vets

TNO0 个研究点目标入组 8 人开始时间: 2020年6月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - aged between 18 and 65 years;
  • - a primary diagnosis of PTSD according to DSM-5, resulting from combat-related trauma(s);
  • - a score of > 20 on the Posttraumatic Symptom Scale at screening.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 8
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - other relevant treatment for PTSD within 3 months before start of the study;
  • - start of new medication within 3 months before start of study;
  • - life-time psychosis;
  • - acute suicide risk;
  • - current state of asthma or COPD, which necessitates medication use;
  • - cardiovascular diseases or irregular heartbeat;
  • - hypotension or hypertension;
  • - pregnancy or breastfeeding;
  • - epilepsy;
  • - any medication contra-indicative of the use of propranolol.

研究者

发起方
TNO

相似试验